Profil
Eileen Wang, formerly the Director of Investor Relations at China Traditional Chinese Medicine Holdings Co. Ltd., later served as the Executive Director and Head of Investor Relations at Wuxi Biologics (Cayman), Inc. from 2017 to 2023.
She also worked as the Manager of Investor Relations at The United Laboratories International Holdings Ltd.
Anciens postes connus de Eileen Wang
| Sociétés | Poste | Fin |
|---|---|---|
| CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED | Investor Relations Contact | - |
| WUXI BIOLOGICS (CAYMAN) INC. | Directeur/Membre du Conseil | 01/01/2023 |
| THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
The United Laboratories International Holdings Ltd.
The United Laboratories International Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company, which engages in the manufacturing and sale of medicines, & the bulk and intermediate products | Health Technology |
China Traditional Chinese Medicine Holdings Co. Ltd.
China Traditional Chinese Medicine Holdings Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates investment holding company, which engages in research and development and production and sale of pharmaceutical products | Health Technology |
Wuxi Biologics (Cayman), Inc.
Wuxi Biologics (Cayman), Inc. BiotechnologyHealth Technology Engages in discovery, development and manufacturing of biologics | Health Technology |
















